The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNAK.L Regulatory News (NAK)

  • There is currently no data for NAK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

29 Dec 2020 10:26

RNS Number : 9990J
Nakama Group Plc
29 December 2020
 

29 December 2020

 Nakama Group plc

 

("Nakama" or the "Company")

 

Result of General Meeting

 

Nakama (AIM:NAK) announces that, at its General Meeting held earlier today, both resolutions proposed were duly passed unanimously. Accordingly, the disposal of the Company's four operating businesses to the Sanderson Group is expected to complete at 5 p.m. on 4 January 2021 ("Completion").

 

Following Completion, the Company will become an AIM Rule 15 cash shell and as such, will either be required to make an acquisition or acquisitions constituting a reverse takeover under AIM Rule 14 on or before the date falling six months from Completion or be re-admitted to trading on AIM as an investing company under the AIM Rules (which requires the raising of at least £6 million) failing which, the Company's ordinary shares would then be suspended from trading on AIM pursuant to AIM Rule 40. Admission to trading of the Company's ordinary shares on AIM would be cancelled six months from the date of any suspension should the suspension not have been lifted beforehand.

 

Change of name

 

The change of the Company's name to Ridgecrest plc will become effective upon the issuance by the Registrar of Companies of a Certificate of Change of Name. A further announcement will be made when trading in the Company's ordinary shares on AIM under the name Ridgecrest plc is to become effective.

 

Board changes

 

Robert Thesiger, Chief Executive of Nakama, will join the Sanderson Group, on a consultancy basis, pursuant to the Disposal. Robert Thesiger will, however, remain as a director of Nakama. The Board has also decided that, upon Completion, Mr Thesiger will become Chairman of the Company and Tim Sheffield will remain as a Non-Executive Director. Michael Clelland will resign as a Non-Executive Director of Nakama upon Completion.

 

Defined terms used in this announcement have the same meaning as in the Company's announcement of 9 December 2020, unless the context requires otherwise.

 

Enquiries:

 

Nakama Group plc

www.nakamaglobal.com

Tim Sheffield, Chairman

00 44 20 7236 2400

Robert Thesiger, Chief Executive Officer

 

 

00 44 20 3588 4560

Allenby Capital Limited (Nominated Adviser and Broker)

00 44 20 3328 5656

Nick Naylor / Liz Kirchner (Corporate Finance)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMUKURRRSUUUAA
Date   Source Headline
29th Dec 202010:26 amRNSResult of General Meeting
22nd Dec 20201:33 pmRNSHolding(s) in Company
22nd Dec 20201:22 pmRNSHolding(s) in Company
17th Dec 202012:18 pmRNSHolding(s) in Company
17th Dec 20209:10 amRNSHoldings in Company and PDMR/PCA dealing
16th Dec 20202:16 pmRNSHolding(s) in Company
15th Dec 20207:00 amRNSHolding(s) in Company
14th Dec 20207:30 amRNSHalf-year Report
14th Dec 20207:00 amRNSFinal Results
11th Dec 202012:06 pmRNSHolding(s) in Company
9th Dec 202011:15 amRNSProposed disposal of operating businesses
13th Nov 20207:00 amRNSTrading and corporate update
1st Oct 202011:37 amRNSHolding(s) in Company
28th Sep 20203:57 pmRNSHolding(s) in Company
25th Sep 202012:00 pmRNSHolding(s) in Company
21st Sep 202012:15 pmRNSHolding(s) in Company
21st Sep 20207:00 amRNSTrading Update and FY Results deadline extension
8th Sep 202011:58 amRNSHolding(s) in Company
7th Sep 202012:59 pmRNSHolding(s) in Company
28th Apr 20205:30 pmRNSHolding(s) in Company
20th Apr 20207:00 amRNSHolding(s) in Company
14th Apr 20207:00 amRNSUpdating on trading and current financial position
11th Feb 20207:00 amRNSTrading update
13th Dec 20197:00 amRNSUnaudited Interim Results
17th Oct 201911:16 amRNSResult of Annual General Meeting and Board Changes
8th Oct 20197:00 amRNSDirectorate Changes
24th Sep 20192:38 pmRNSPosting of Annual Report & Notice of AGM
19th Sep 20192:12 pmRNSHolding(s) in Company
18th Sep 20197:00 amRNSFinal Results and Notice of AGM
28th Mar 20192:00 pmRNSDirectorate Change
21st Jan 20191:30 pmRNSTrading Update
13th Dec 20187:00 amRNSHolding(s) in Company
27th Nov 201811:37 amRNSHolding(s) in Company
26th Nov 201811:06 amRNSHolding(s) in Company
20th Nov 20187:00 amRNSUnaudited Interim Results and Board Appointment
16th Nov 20183:48 pmRNSHolding(s) in Company
12th Nov 20184:15 pmRNSHolding(s) in Company
8th Nov 201810:08 amRNSHolding(s) in Company
6th Nov 20189:36 amRNSHolding(s) in Company
26th Sep 20182:30 pmRNSResult of AGM
10th Sep 20187:00 amRNSFinal Results
3rd Sep 20187:00 amRNSNotice of AGM
26th Jul 20187:00 amRNSDirectorate Change
11th Jul 20189:13 amRNSTrading and corporate update and Board change
25th May 20187:00 amRNSBoard change, appointment of part-time FD & update
9th Apr 20188:25 amRNSCorporate update and director resignation
22nd Mar 20187:00 amRNSChange of Adviser
27th Feb 201812:38 pmRNSTrading Update
30th Jan 20187:00 amRNSDirectorate Change
7th Dec 20177:00 amRNSAppointment of Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.